Clinical Trial

Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2025 (before its estimated December 24, 2025 completion). Its status may not reflect the trial's current state.
Summary
Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-19; most recent amendment 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2025-09-17
Trial Details
NCT Number NCT06894875
Lead Sponsor Nuritas Ltd
Collaborators: Australian Catholic University, Baker Heart and Diabetes Institute
Conditions Exercise, Blood Pressure, Vasodilation, Vascular Function in Healthy Volunteers, Exercise Performance, Safety and Tolerability in Healthy Volunteers
Enrollment 48 participants
Start Date 2025-06-24
Primary Completion 2025-12-24 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-16